The rising prevalence in GLP-1 agonists for metabolic conditions has generated a debate about formats: patches versus pills . Usually , GLP-1 therapies were only available in pill form, but the https://laylartpj659335.ja-blog.com/41260739/glp-1-transdermal-delivery-systems-vs-pills-what-best-for-individuals